author-photo

Satish Kumar Ramraj

University of Oklahoma Health Sciences Center

17

Papers

106

Citations

Citation Trend

Filter By

Papers (17) Sort By

JournalConferenceOthers

Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53

2020 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (10)
Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer.

2020 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Abstract NT-104: SYNERGISTIC COMBINATION OF MORTALIN-TARGETING AND P53 REACTIVATOR DRUGS FOR OVARIAN CANCER

2019 Clinical Cancer Research
- Satish Kumar Ramraj
- Doris M. Benbrook
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-244: Prevention of ovarian cancer tumor establishment with mortalin targeting and p53 reactivator drugs

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4652: Repurposing mebendazole in combination with PRIMA1METfor ovarian cancer therapy

2019 Tumor Biology
Show All
- Source
- Cite
- Save
Citations (0)
Correlation of clinical data with fallopian tube specimen immune cells and tissue culture capacity

2018 Tissue & Cell
Show All
- Source
- Cite
- Save
Citations (3)
Abstract 3225: SHetA2 targets mortalin-p53 interaction in differential induction of apoptosis in ovarian cancer over normal cells

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (23)
Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer

2015 Stem Cell Research & Therapy
Show All
- Source
- Cite
- Save
Citations (23)
RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes

2015 Oncotarget
Show All
- Source
- Cite
- Save
Citations (10)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号